后弹力层剥离内皮角膜移植术十年移植片存活与内皮细胞丢失
10年平均内皮细胞丢失73.1%,术前青光眼、既往青光眼手术及再移植是移植片失败的危险因素。
要点
- DSEK术后10年累积移植片存活率全组为79%,Fuchs内皮营养不良者为92%。
- 10年平均内皮细胞丢失达73.1%,但移植片存活率仍较高且视力良好。
- 术前青光眼、既往青光眼手术及再移植是移植片失败的显著危险因素。
核心结论
- DSEK术后10年全组移植片存活率为79%,Fuchs内皮营养不良者为92%。
- 尽管10年平均内皮细胞密度仅692 cells/mm2,移植片存活率仍较高且视力良好。
- DSEK仍是可行的治疗选择,尤其适用于合并症复杂的患眼。
主要发现
- 全组1、3、5、10年累积移植片存活率分别为97%、90%、85%、79%。
- Fuchs内皮营养不良10年移植片存活率为92%。
- 全组平均内皮细胞丢失百分比1年为46.6%±17.3%,3年为54.9%±18.7%,5年为59.6%±17.4%,10年为73.1%±9.7%。
临床怎么用
- 术前合并青光眼或既往青光眼手术者DSEK术后移植片失败风险显著增高,需加强随访。
- 再移植眼DSEK术后移植片失败风险亦显著增高,应密切监测。
- Fuchs内皮营养不良患者DSEK术后10年移植片存活率较高,预后相对良好。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine 10-year outcomes for graft and endothelial cell survival after Descemet stripping endothelial keratoplasty (DSEK), including risk factors for graft failure. DESIGN: Retrospective clinical cohort study. METHODS: Three hundred fifty-six consecutive DSEK grafts performed by 10 surgeons using a standardized protocol were analyzed. Primary outcomes were cumulative graft survival and percentage endothelial cell loss (ECL) from 6 months to 10 years; secondary outcomes included risk factors for graft failure, postoperative complications, visual outcomes, and central corneal thickness. RESULTS: Indications include Fuchs endothelial dystrophy (n = 209), bullous keratopathy (n = 88), and previous graft failure (n = 39). One hundred and four eyes (29%) had preoperative glaucoma. Cumulative graft survival rates of all eyes at 1, 3, 5, and 10 years were 97%, 90%, 85%, and 79%, respectively. Ten-year graft survival for Fuchs endothelial dystrophy was 92%. Mean ± SD percentage ECL of all grafts was 46.6% ± 17.3% at year 1, 54.9% ± 18.7% at year 3, 59.6% ± 17.4% at year 5, and 73.1% ± 9.7% at year 10. Cox regression identified preoperative glaucoma (hazard ratio [HR]: 8.41; 95% CI, 1.30-54.5; P = .026), including previous glaucoma surgery (HR: 3.63; 95% CI: 1.03-12.74; P = .04) and regrafts (HR: 5.29; 95% CI: 2.02-13.89; P = .001) as significant risk factors for graft failure. CONCLUSIONS: At 10 years, DSEK survival rate was 79% for all eyes, including complex grafts, and ECL was 73%. For Fuchs endothelial dystrophy, 10-year graft survival rate was 92%. Despite a mean 10-year endothelial cell count of only 692 cells/mm2, graft survival remained high with good vision. DSEK continues to be a viable treatment option, especially in complex eyes with comorbidity.
引用
- Fu L, Hollick EJ. Long-term Outcomes of Descemet Stripping Endothelial Keratoplasty: Ten-Year Graft Survival and Endothelial Cell Loss. Am J Ophthalmol. 2021. PMID: 34416181. doi:10.1016/j.ajo.2021.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。